Outcome of Board Meeting
Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2016, the Company has been holding 5,440 equity shares in Thyrocare International Holding Co., (TIHC) Mauritius, representing 9.09% of the total paid-up capital of the said company, which is not yielding any return.Further, the recommendation of the Audit Committee, approved a proposal to sell the entire 5,440 equity shares... Fixes Book Closure for Final Dividend & AGM
Thyrocare Technologies Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 05, 2016 to September 12, 2016 (both days inclusive) for the purpose of Payment of Final Dividend & 16th Annual General Meeting (AGM) of the Company to be held on September 12, 2016. Adding one lab every quarter should take care of growth needs: A Velumani, Thyrocare Technologies
"If we lose margins, we will be losing half a per cent per year. Next 10 years we might touch 30 if we cannot sustain today's margins." Standalone & Consolidated Financial Results, Limited Review Report for June 30, 2016
Thyrocare Technologies Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Consolidated Financial Results for the period ended June 30, 20163. Standalone Limited Review for the period ended June 30, 20164. Consolidated Limited Review for the period ended June 30, 2016 Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Thyrocare Technologies Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended June 30, 2016
Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Board Meeting Intimation for Results & Closure of Trading Window
Thyrocare Technologies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 22, 2016, inter alia, to consider and approve unaudited Stand-alone financial results of the Company for the quarter ended June 30, 2016.The Company also be submitting the unaudited Consolidated financial results of the Company and its subsidiary for the above quarter.... Zenify partners with Thyrocare
The partnership will facilitate an exclusive wellness package for the former's esteemed customers Intimation of Schedule of Analyst / Institutional Investor Meetings
Thyrocare Technologies Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings" Intimation of Conference Call
Thyrocare Technologies Ltd has informed BSE regarding "Intimation of Conference Call".